These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28446050)

  • 21. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease.
    Cengiz M; Ozenirler S
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1293-9. PubMed ID: 26302023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD.
    Tamaki N; Munaganuru N; Jung J; Yonan AQ; Bettencourt R; Ajmera V; Valasek MA; Behling C; Loomba R
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2673-2674.e3. PubMed ID: 33157318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease.
    Ou H; Fu Y; Liao W; Zheng C; Wu X
    Can J Gastroenterol Hepatol; 2019; 2019():6028952. PubMed ID: 31737583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    D'Ambrosio R; Campi I; Maggioni M; Perbellini R; Giammona E; Stucchi R; Borghi M; Degasperi E; De Silvestri A; Persani L; Fugazzola L; Lampertico P
    PLoS One; 2021; 16(4):e0249614. PubMed ID: 33822817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.
    Goh GB; Pagadala MR; Dasarathy J; Unalp-Arida A; Pai RK; Yerian L; Khiyami A; Sourianarayanane A; Sargent R; Hawkins C; Dasarathy S; McCullough AJ
    Dig Dis Sci; 2015 Jun; 60(6):1825-31. PubMed ID: 25708897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
    Angulo P; Kleiner DE; Dam-Larsen S; Adams LA; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Keach JC; Lafferty HD; Stahler A; Haflidadottir S; Bendtsen F
    Gastroenterology; 2015 Aug; 149(2):389-97.e10. PubMed ID: 25935633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease.
    Lee HW; Lee DH; Lee JK; Lee S; Koo BK; Joo SK; Heo EY; Jung YJ; Kim W; Kim DK
    Liver Int; 2020 Dec; 40(12):3008-3017. PubMed ID: 32737958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
    Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
    J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
    Dogan S; Celikbilek M; Yilmaz YK; Sarikaya S; Zararsiz G; Serin HI; Borekci E; Akyol L; Pirti I; Davarci SE
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):298-304. PubMed ID: 25629574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Alcoholic Fatty Liver Disease Is Strongly Associated with Smoking Status and Is Improved by Smoking Cessation in Japanese Males: A Retrospective Study.
    Takenaka H; Fujita T; Masuda A; Yano Y; Watanabe A; Kodama Y
    Kobe J Med Sci; 2020 Nov; 66(3):E102-E112. PubMed ID: 33431783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAF score and mortality in NAFLD after up to 41 years of follow-up.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Stål P; Bedossa P; Hultcrantz R
    Scand J Gastroenterol; 2017 Jan; 52(1):87-91. PubMed ID: 27616339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
    Vilar-Gomez E; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Friedman SL; Diago M; Romero-Gomez M
    Gastroenterology; 2015 Aug; 149(2):367-78.e5; quiz e14-5. PubMed ID: 25865049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of Alpha 1 Antitrypsin Risk Variants is Not Associated With Histologic Severity of Pediatric NAFLD.
    Khan M; Klepper C; Orkin S; Arce-Clachar AC; Bramlage K; Fei L; Miethke A; Kohli R; Xanthakos S; Mouzaki M
    J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):166-170. PubMed ID: 37229749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies.
    Lin TY; Yeh ML; Huang CF; Huang CI; Dai CY; Hsieh MH; Chen SC; Huang JF; Yu ML; Chuang WL
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):224-229. PubMed ID: 30308578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease.
    Björkström K; Stål P; Hultcrantz R; Hagström H
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1461-1468. PubMed ID: 28479500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.